Zkusit zdarma
Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc.

APLS
Cena:
$ 41.03
0.00 (0.00%)
Valuace
0
Růst
40
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

17:00 07-05-2026

The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed ...

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

16:26 07-05-2026

Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $0.15 per share, beating th...

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

13:34 10-04-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of “Hold” by Analysts

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of “Hold” by Analysts

3:18 10-04-2026

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) have received an average re...

Shareholder Alert: Ademi LLP investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

7:33 07-04-2026

MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Apellis (NASDAQ: APLS) for ...

Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get

Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get

6:40 06-04-2026

Apellis jumps as Biogen agrees $5.6 Billion acquisition, offering $41/share plus milestones, boostin...

Apellis Pharmaceuticals (NASDAQ:APLS) Hits New 52-Week High – Should You Buy?

Apellis Pharmaceuticals (NASDAQ:APLS) Hits New 52-Week High – Should You Buy?

4:49 02-04-2026

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) hit a new 52-week high duri...

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

16:07 01-04-2026

NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & ...

Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?

Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?

8:55 01-04-2026

Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. T...

Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS

Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS

22:08 31-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

12:00 31-03-2026

MILWAUKEE, March 31, 2026 /PRNewswire/ -- Ademi LLP is investigating Apellis (NASDAQ: APLS) for poss...

Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?

Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?

11:38 31-03-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

Why This Pharma Stock More Than Doubled Today

Why This Pharma Stock More Than Doubled Today

9:41 31-03-2026

A small biopharmaceutical firm was getting a big boost Tuesday after Biogen agreed to buy it for $5....

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

8:20 31-03-2026

Biogen Inc (NASDAQ:BIIB, XETRA:IDP) will acquire Apellis Pharmaceuticals Inc (NASDAQ:APLS) for $41 ...

APLS Stock Alert: Halper Sadeh LLC is Investigating Whether Apellis Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

APLS Stock Alert: Halper Sadeh LLC is Investigating Whether Apellis Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

7:56 31-03-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

12:32 26-03-2026

Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock?...

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

19:19 21-03-2026

RTW Investments established a new position in Apellis Pharmaceuticals, adding 7,666,764 shares durin...

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

12:01 24-02-2026

Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $0.47 per share, beating th...

Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

12:01 24-02-2026

While the top- and bottom-line numbers for Apellis Pharmaceuticals (APLS) give a sense of how the bu...

Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript

Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript

11:48 24-02-2026

Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript...

close

APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON FEBRUARY 24, 2026, TO DISCUSS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

10-02-2026
WALTHAM, MASS., FEB. 10, 2026 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS , INC. (NASDAQ: APLS) TOD...
Více zde

TTM TECHNOLOGIES, DUTCH BROS, ADVANCED ENERGY INDUSTRIES, AND AMERICAN HEALTHCARE REIT SET TO JOIN S&P MIDCAP 400; OTHERS TO JOIN S&P SMALLCAP 600

27-01-2026
NEW YORK, JAN. 27, 2026 /PRNEWSWIRE/ -- S&P DOW JONES INDICES WILL MAKE THE FOLLOWING CHANGES TO TH...
Více zde

APELLIS HIGHLIGHTS COMMERCIAL EXECUTION AND STRATEGIC PRIORITIES AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

12-01-2026
WALTHAM, MASS., JAN. 12, 2026 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS), TOD...
Více zde

APELLIS PHARMACEUTICALS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
WALTHAM, MASS., JAN. 05, 2026 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE PHASE 3 VALIANT RESULTS OF EMPAVELI® (PEGCETACOPLAN) FOR C3G AND PRIMARY IC-MPGN

03-12-2025
WALTHAM, MASS., DEC. 03, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

25-11-2025
WALTHAM, MASS., NOV. 25, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS ANNOUNCES 5-YEAR GALE DATA SHOWING SYFOVRE® (PEGCETACOPLAN INJECTION) DELAYED PROGRESSION OF GEOGRAPHIC ATROPHY BY ~1.5 YEARS

12-11-2025
WALTHAM, MASS., NOV. 12, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS TO PRESENT AT THE STIFEL 2025 HEALTHCARE CONFERENCE

05-11-2025
WALTHAM, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

30-10-2025
WALTHAM, MASS., OCT. 30, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS), TOD...
Více zde

NEW ONE-YEAR DATA REINFORCING THE ROBUST AND SUSTAINED EFFICACY OF EMPAVELI® (PEGCETACOPLAN) IN C3G AND PRIMARY IC-MPGN TO BE PRESENTED AT ASN KIDNEY WEEK

20-10-2025
WALTHAM, MASS., OCT. 20, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON OCTOBER 30, 2025, TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS

16-10-2025
APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON OCTOBER 30, 2025, TO DISCUSS THIRD QUARTER 2025 F...
Více zde

APELLIS PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-08-2025
WALTHAM, MASS., AUG. 27, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODA...
Více zde

APELLIS PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

31-07-2025
WALTHAM, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS), TOD...
Více zde

FDA APPROVES APELLIS' EMPAVELI® (PEGCETACOPLAN) AS THE FIRST C3G AND PRIMARY IC-MPGN TREATMENT FOR PATIENTS 12 AND OLDER

28-07-2025
WALTHAM, MASS., JULY 28, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON JULY 31, 2025, TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS

24-07-2025
WALTHAM, MASS., JULY 24, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS , INC. (NASDAQ: APLS) TOD...
Více zde

APELLIS ANNOUNCES FIVE ABSTRACTS ACCEPTED FOR ORAL PRESENTATION AT THE AMERICAN SOCIETY OF RETINA SPECIALISTS (ASRS) ANNUAL SCIENTIFIC MEETING

15-07-2025
WALTHAM, MASS., JULY 15, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

SOBI TO AMEND EXISTING AGREEMENT WITH APELLIS FOR EX-U.S. ROYALTIES OF ASPAVELI® (SYSTEMIC PEGCETACOPLAN)

01-07-2025
STOCKHOLM , JULY 1, 2025 /PRNEWSWIRE/ -- SOBI® (STO: SOBI), TODAY ANNOUNCED A CAPPED ROYALTY PURCHA...
Více zde

APELLIS TO RECEIVE UP TO $300 MILLION FROM ROYALTY PURCHASE AGREEMENT WITH SOBI FOR EX-U.S. ROYALTIES OF ASPAVELI® (SYSTEMIC PEGCETACOPLAN)

01-07-2025
WALTHAM, MASS., JULY 01, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS AND SOBI ANNOUNCE EMPAVELI® (PEGCETACOPLAN) SHOWED SUSTAINED EFFICACY AT ONE YEAR IN PHASE 3 STUDY FOR C3G AND PRIMARY IC-MPGN

06-06-2025
WALTHAM, MASS. AND STOCKHOLM, JUNE 06, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDA...
Více zde

APELLIS PHARMACEUTICALS TO PRESENT AT THE GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

04-06-2025
WALTHAM, MASS., JUNE 04, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODA...
Více zde

APELLIS PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

07-05-2025
WALTHAM, MASS., MAY 07, 2025 (GLOBE NEWSWIRE) --  APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS), TO...
Více zde

APELLIS PHARMACEUTICALS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

06-05-2025
WALTHAM, MASS., MAY 06, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY...
Více zde

APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON MAY 7, 2025, TO DISCUSS FIRST QUARTER 2025 FINANCIAL RESULTS

30-04-2025
WALTHAM, MASS., APRIL 30, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS , INC. (NASDAQ: APLS) TO...
Více zde

APELLIS ANNOUNCES CRAIG WHEELER TO JOIN THE BOARD OF DIRECTORS

21-04-2025
WALTHAM, MASS., APRIL 21, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODA...
Více zde

APELLIS ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR EMPAVELI® (PEGCETACOPLAN) FOR C3G AND PRIMARY IC-MPGN

01-04-2025
PDUFA TARGET ACTION DATE IS JULY 28, 2025 WALTHAM, MASS., APRIL 01, 2025 (GLOBE NEWSWIRE) -- APELLIS...
Více zde

APELLIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

28-02-2025
WALTHAM, MASS., FEB. 28, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS), TOD...
Více zde

APELLIS PHARMACEUTICALS TO PRESENT AT THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE

24-02-2025
WALTHAM, MASS., FEB. 24, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODA...
Více zde

APELLIS AND SOBI ANNOUNCE EMA VALIDATION OF INDICATION EXTENSION APPLICATION FOR ASPAVELI® (PEGCETACOPLAN) FOR C3G AND PRIMARY IC-MPGN

20-02-2025
WALTHAM, MASS. AND STOCKHOLM, SWEDEN, FEB. 20, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC...
Více zde

APELLIS PHARMACEUTICALS TO HOST CONFERENCE CALL ON FEBRUARY 28, 2025, TO DISCUSS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

14-02-2025
WALTHAM, MASS., FEB. 14, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS , INC. (NASDAQ: APLS) TOD...
Více zde

APELLIS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-02-2025
WALTHAM, MASS., FEB. 04, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) ANNO...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-10-30 00:00:0010-QStáhnout
2025-07-31 01:00:0010-QStáhnout
2025-07-31 00:00:0010-QStáhnout
2025-07-01 01:00:008-KStáhnout
2025-07-01 00:00:008-KStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-04-21 01:00:008-KStáhnout
2025-04-21 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-05 00:00:0010-QStáhnout
2024-11-04 23:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-01 01:00:0010-QStáhnout
2024-08-01 00:00:0010-QStáhnout
2024-06-05 01:00:008-KStáhnout
2024-06-05 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 00:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-01-22 00:00:008-KStáhnout
2024-01-21 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-14 00:00:008-KStáhnout
2023-12-13 23:00:008-KStáhnout
2023-12-01 00:00:008-KStáhnout
2023-11-30 23:00:008-KStáhnout
2023-11-01 00:00:008-KStáhnout
2023-11-01 00:00:0010-QStáhnout
2023-10-31 23:00:008-KStáhnout
2023-10-31 23:00:0010-QStáhnout
2023-10-05 01:00:008-KStáhnout
2023-10-05 00:00:008-KStáhnout
2023-08-29 01:00:008-KStáhnout
2023-08-29 00:00:008-KStáhnout
2023-08-22 01:00:008-KStáhnout
2023-08-22 00:00:008-KStáhnout
2023-07-31 01:00:008-KStáhnout
2023-07-31 01:00:0010-QStáhnout
2023-07-31 00:00:008-KStáhnout
2023-07-31 00:00:0010-QStáhnout
2023-07-17 01:00:008-KStáhnout
2023-07-17 00:00:008-KStáhnout
2023-06-01 01:00:008-KStáhnout
2023-06-01 00:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-02-24 00:00:008-KStáhnout
2023-02-23 23:00:008-KStáhnout
2023-02-21 00:00:0010-KStáhnout
2023-02-20 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-11-07 00:00:0010-QStáhnout
2022-11-06 23:00:0010-QStáhnout
2022-08-24 01:00:008-KStáhnout
2022-08-24 00:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-08-02 01:00:008-KStáhnout
2022-08-02 00:00:008-KStáhnout
2022-07-27 01:00:008-KStáhnout
2022-07-27 00:00:008-KStáhnout
2022-07-19 01:00:008-KStáhnout
2022-07-19 00:00:008-KStáhnout
2022-06-02 01:00:008-KStáhnout
2022-06-02 00:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-03-25 00:00:008-KStáhnout
2022-03-24 23:00:008-KStáhnout
2022-03-16 00:00:008-KStáhnout
2022-03-15 23:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-01-20 00:00:008-KStáhnout
2022-01-19 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-17 00:00:008-KStáhnout
2021-11-16 23:00:008-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-30 01:00:008-KStáhnout
2021-08-30 00:00:008-KStáhnout
2021-08-19 01:00:008-KStáhnout
2021-08-19 00:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-07-26 01:00:008-KStáhnout
2021-07-26 00:00:008-KStáhnout
2021-07-08 01:00:008-KStáhnout
2021-07-08 00:00:008-KStáhnout
2021-06-30 01:00:008-KStáhnout
2021-06-30 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-04-28 01:00:0010-QStáhnout
2021-04-28 00:00:0010-QStáhnout
2021-03-11 00:00:008-KStáhnout
2021-03-10 23:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-01-26 00:00:008-KStáhnout
2021-01-25 23:00:008-KStáhnout
2021-01-07 00:00:008-KStáhnout
2021-01-06 23:00:008-KStáhnout
2021-01-04 00:00:008-KStáhnout
2021-01-03 23:00:008-KStáhnout
2020-11-02 00:00:0010-QStáhnout
2020-11-01 23:00:0010-QStáhnout
2020-10-27 00:00:008-KStáhnout
2020-10-26 23:00:008-KStáhnout
2020-07-30 01:00:0010-QStáhnout
2020-07-30 00:00:0010-QStáhnout
2020-06-01 01:00:008-KStáhnout
2020-06-01 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 00:00:008-KStáhnout
2020-04-29 01:00:0010-QStáhnout
2020-04-29 00:00:0010-QStáhnout
2020-04-06 01:00:008-KStáhnout
2020-04-06 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-01-09 00:00:008-KStáhnout
2020-01-08 23:00:008-KStáhnout
2020-01-07 00:00:008-KStáhnout
2020-01-06 23:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-10-07 01:00:008-KStáhnout
2019-10-07 00:00:008-KStáhnout
2019-09-16 01:00:008-KStáhnout
2019-09-16 00:00:008-KStáhnout
2019-09-12 01:00:008-KStáhnout
2019-09-12 00:00:008-KStáhnout
2019-09-11 01:00:008-KStáhnout
2019-09-11 00:00:008-KStáhnout
2019-07-31 01:00:0010-QStáhnout
2019-07-31 00:00:0010-QStáhnout
2019-06-21 01:00:008-KStáhnout
2019-06-21 00:00:008-KStáhnout
2019-06-10 01:00:008-KStáhnout
2019-06-10 00:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-04-12 01:00:008-KStáhnout
2019-04-12 00:00:008-KStáhnout
2019-03-07 00:00:008-KStáhnout
2019-03-06 23:00:008-KStáhnout
2019-03-04 00:00:008-KStáhnout
2019-03-03 23:00:008-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-26 00:00:0010-KStáhnout
2019-02-25 23:00:0010-KStáhnout
2018-12-20 00:00:008-KStáhnout
2018-12-19 23:00:008-KStáhnout
2018-11-13 00:00:0010-QStáhnout
2018-11-12 23:00:0010-QStáhnout
2018-10-17 01:00:008-KStáhnout
2018-10-17 00:00:008-KStáhnout
2018-09-04 01:00:008-KStáhnout
2018-09-04 00:00:008-KStáhnout
2018-07-31 01:00:0010-QStáhnout
2018-07-31 00:00:0010-QStáhnout
2018-06-05 01:00:008-KStáhnout
2018-06-05 00:00:008-KStáhnout
2018-04-30 01:00:0010-QStáhnout
2018-04-30 00:00:0010-QStáhnout
2018-04-02 01:00:008-KStáhnout
2018-04-02 00:00:008-KStáhnout
2018-03-19 00:00:0010-KStáhnout
2018-03-18 23:00:0010-KStáhnout
2017-12-20 00:00:0010-QStáhnout
2017-12-19 23:00:0010-QStáhnout
2017-11-13 00:00:008-KStáhnout
2017-11-12 23:00:008-KStáhnout
preloader